NCT06499454View on ClinicalTrials.gov

Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Lung CancerLung Diseases
Interventions
DIAGNOSTIC_TEST

Ruby ROSE evaluation

Creation and digitization of ROSE slides produced using Ruby's instrument from bronchoscopic biopsy samples

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Ruby Robotics Inc

INDUSTRY

NCT06499454 - Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel Instrument | Biotech Hunter | Biotech Hunter